Showing posts with label Flow Cytometry Market. Show all posts
Showing posts with label Flow Cytometry Market. Show all posts

Thursday, 24 May 2018

Flow Cytometry Market to Register a CAGR of 11.0% from 2017 to 2025

Transparency Market Research (TMR) in its latest research report on the global flow cytometry market states that leading players within this market are offering advanced products such as products with ultraviolet and infrared lasers or even avalanche photodiode sensors. The report further states that players within the market are attempting to expand their product portfolio as well as their geographical reach with other companies. This step is becoming increasingly essential so as to improve their biological product and drug analysis. The leading players within the market namely Dickinson and Company (BD), Becton, Merck & Co., Inc., and Beckman Coulter, Inc. (Danaher) accounted for a whopping 50% of the total market in 2016.
According to TMR, the global flow cytometry market is anticipated to expand it 11% CAGR between 2017 and 2025 and be worth US$8100 mn by 2025. On the basis of geography, key markets within the flow cytometry market are North America and Europe due to the efforts taken by players within these regions to develop Advanced flow cytometry instruments. Players Within the market in these two regions are also entering into distribution agreements which are resulting in strengthening their positions in the market. Asia-pacific is also anticipated to be a lucrative regional market in the years to come and expanded a healthy 13% CAGR during the forecast period.
Use of Flow Cytometry Instruments to Increase on Account of Extensive Use in Target Based and Novel Drug Discovery
On the basis of product and service, the flow cytometry instruments segment has been leading in the market and is expected to continue to do so on account of the rising use of advanced flow cytometry instruments for target based drug discovery as well as novel drug discovery. The highest growth rate within the product and service segments is anticipated to be witnessed by the reagents and consumable segment. Fast growth is expected to be witnessed in the years to come by the reagents and consumable segments on account of the consistent efforts taken by market players in order to achieve innovation in the product technologies.
In terms of application, the pharmaceutical and Drug Discovery segment is leading and will continue to do so, expanding at the 10% CAGR between 2017 and 2025 on account of growing innovation in flow cytometry instruments as well as an increase in the product portfolio thanks to the efforts by manufacturers.
Growing Demand for Point-Of-Care Testing Driving Growth of Flow Cytometry Market
According to the lead author of this report, there has been a tremendous rise in the demand for flow cytometry on account of the rise in the diagnosis of systemic diseases. The growth of the flow cytometry market is also linked with the rise in the prevalence of cancer, HIV, AIDS, immunological diseases and similar other chronic diseases. An increasing number of doctors are showing inclination towards the use of allergenic and autologous stem cell therapies instead of using radiation and chemotherapy and this is the resulting in an upsurge in the demand for flow cytometers. The demand for flow cytometry is also anticipated to increase on account of the growing demand for point-of-care testing for disease management of patients suffering from chronic diseases. Moreover, increasing investments of time and money towards research and development, by leading players will work in the favour of the growth of the global flow cytometry market as the efforts in this direction is leading to the development of advanced reagents as well as multicolor assays.
Image and Scanning Cytometers Threatening Demand for Flow Cytometry
Enhanced accuracy, cost-effectiveness, and portability are other positive results of R&D by players within the market, which is expected to drive the growth prospects of this market. On the other hand, the growth of this market is threatened by substitute such as image and scanning cytometers. A lack of awareness will also impact the markets negatively to a certain extent.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Tuesday, 5 December 2017

Flow Cytometry Market to Grow at a CAGR of 7.1% During the Period of Assessment 2017-2022

Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing. The global flow cytometry market is influenced by various factors such as medical and technological developments in flow cytometry products, rising use of flow cytometry in clinical trials, in detection of blood cancer, in research, in launching of new reagents for critical applications such as drug discovery and diagnostics and also in development of intuitive and user-friendly software are fuelling the growth of the flow cytometry market in the forthcoming timeline. Moreover, rising prevalence of AIDS and cancer has triggered the adoption of flow cytometry technology in scientific research. This is supporting the growth of the global flow cytometry market.


The analytical and extensive research report on “Flow Cytometry Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022)” published by Future Market Insights uncovers various factors of the global market for flow cytometry which can be used to analyse and grasp opportunities in the market across regions worldwide in order to carry out expansion programs in the future. According to the market analysis in this research report, the global flow cytometry market is projected to grow at a VAGR of 7.1% during the period of assessment 2017-2022.

By application, the research segment is expected to dominate the global market with respect to high market share. By the end of 2022, this segment is estimated to reach a high market valuation of around US$ 1.8 Bn growing at a high CAGR during this period. The industrial segment is projected to grow at the highest rate during the assessment period and poised to gain a high BPS by the end of 2022.


By technology, the cell based segment is the largest segment. It is projected to grow at a CAGR of 7.2% throughout the period of forecast and is estimated to gain a very high valuation during the period of assessment

By end user, the commercial organizations segment is expected to gain the highest BPS by end of 2022. Moreover, this segment demands increasing use of flow cytometry and is the largest and the fastest growing segment in the flow cytometry market

The global flow cytometry market research study includes a separate section on competitive landscape in which it focuses on the key players and their in-depth analysis including company overview, SWOT analysis, developments, innovations, key financials and product portfolios. This extensive research report covers key companies such as Miltenyi Biotec GmbH, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck & Co Inc., Agilent Technologies, Inc., Sysmex Corporation, Becton Dickinson and Company and Danaher Corporation.

Buy Full Flow Cytometry Market Report @ https://www.futuremarketinsights.com/checkout/5263

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com

Website: www.futuremarketinsights.com

Friday, 1 December 2017

Flow Cytometry Market to Reach Around US$ 4.4 Billion by the End of 2022

Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing. The global flow cytometry market is influenced by various factors such as medical and technological developments in flow cytometry products, rising use of flow cytometry in clinical trials, in detection of blood cancer, in research, in launching of new reagents for critical applications such as drug discovery and diagnostics and also in development of intuitive and user-friendly software are fuelling the growth of the flow cytometry market in the forthcoming timeline. Moreover, rising prevalence of AIDS and cancer has triggered the adoption of flow cytometry technology in scientific research. This is supporting the growth of the global flow cytometry market.

Read Report Overview @ https://www.futuremarketinsights.com/reports/flow-cytometry-market

The analytical and extensive research report on “Flow Cytometry Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022)” published by Future Market Insights uncovers various factors of the global market for flow cytometry which can be used to analyse and grasp opportunities in the market across regions worldwide in order to carry out expansion programs in the future. According to the market analysis in this research report, the global flow cytometry market is projected to grow at a VAGR of 7.1% during the period of assessment 2017-2022.

By application, the research segment is expected to dominate the global market with respect to high market share. By the end of 2022, this segment is estimated to reach a high market valuation of around US$ 1.8 Bn growing at a high CAGR during this period. The industrial segment is projected to grow at the highest rate during the assessment period and poised to gain a high BPS by the end of 2022

By technology, the cell based segment is the largest segment. It is projected to grow at a CAGR of 7.2% throughout the period of forecast and is estimated to gain a very high valuation during the period of assessment

By end user, the commercial organizations segment is expected to gain the highest BPS by end of 2022. Moreover, this segment demands increasing use of flow cytometry and is the largest and the fastest growing segment in the flow cytometry market

In the product type category, the reagents and consumables have gained high traction in the recent years. This segment is a high contributor of growth of the global flow cytometry market. The reagents and consumables segment is estimated to gain a high BPS and grow at a high CAGR of 7.9% throughout the period of assessment.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5263

The global flow cytometry market research study includes a separate section on competitive landscape in which it focuses on the key players and their in-depth analysis including company overview, SWOT analysis, developments, innovations, key financials and product portfolios. This extensive research report covers key companies such as Miltenyi Biotec GmbH, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck & Co Inc., Agilent Technologies, Inc., Sysmex Corporation, Becton Dickinson and Company and Danaher Corporation.

CONTACT:

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com